One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey
Pakistan Journal of Medical Sciences · 11.04.2026 · 42 (4) · 979-985
DOI: 10.12669/pjms.42.4.13527 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 11.04.2026. Verfasst von Neslisah Gurel Koksal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neslisah Gurel Koksal, MD Department of Family Medicine, Giresun University Giresun Training, Research Hospital, Giresun, Turkey. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Based on randomized clinical trials, bupropion and nicotine replacement therapy (NRT) are recommended as equally effective first-line pharmacotherapies for smoking cessation. However, long-term real-world observational data comparing these two treatment options are scarce. This study aimed to evaluate 12-month smoking cessation success rates among smokers using bupropion versus those using NRT in a real-world clinical setting. Methodology: This prospective observational cohort study included 235 adult smokers who visited a Smoking Cessation Clinic affiliated with the Community Health Center in Giresun, Turkey, between October 2022 to October 2023. All participants received physician-led counseling and were prescribed either bupropion (n=45) or NRT (n=190; NRT 15 mg, n=118, and NRT 25 mg, n=72). Both treatments were provided free of charge for 12 weeks, during which six scheduled clinical visits were conducted over a 90-day period. Telephone follow-up assessments were conducted at weeks 16, 24 and 52. The primary outcome was the self-reported continuous abstinence at week 52.
Results
The mean age of participants was 40.74 ± 12.42 years, with 59.6% (n=140) being men. The overall 12-month continuous abstinence rate was 69.4% (n=163). The independent predictors of sustained abstinence at 52 weeks were high adherence to treatment, regular attendance at scheduled follow-up visits, counseling along with bupropion or high-dose NRT (25 mg), and fewer adverse effects during treatment.
Conclusion
In real-world clinical practice, bupropion or high-dose NRT (25 mg), combined with structured counseling yielded high long-term abstinence rates and acceptable side effect profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neslisah Gurel Koksal, MD Department of Family Medicine, Giresun University Giresun Training, Research Hospital, Giresun, Turkey.
- Mustafa Koksal, MD Giresun Provincial Directorate of Health, Giresun, Turkey.
Zitieren
APA
Koksal, N. G., & Koksal, M. (2026). One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey. Pakistan Journal of Medical Sciences, 42(4), 979-985. https://doi.org/10.12669/pjms.42.4.13527
Vancouver
Koksal NG, Koksal M. One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey. Pakistan Journal of Medical Sciences. 2026;42(4):979-985. doi:10.12669/pjms.42.4.13527
BibTeX
@article{Koksal2026,
author = {Koksal, Neslisah Gurel and Koksal, Mustafa},
title = {One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
volume = {42},
number = {4},
pages = {979--985},
doi = {10.12669/pjms.42.4.13527}
}
EUVIMED